Download 2014 CANCER PROGRAM ANNUAL REPORT WEBSITE VERSION

Integrative. Innovative. Individualized.
2014
CANCER PROGRAM
ANNUAL REPORT
WEBSITE VERSION
Selected 2013 Cancer Registry Data
2014 Cancer Committee Membership
and Alternates
Fernando U. Garcia, MD
Cancer Committee Chair/Pathology
Jane Fridman, RHIT, CTR
Cancer Conference Coordinator
Nicole Worthington, CPHQ
Quality Improvement Coordinator
Russell Reisner, MD, FACS
Cancer Liaison Physician/Surgeon
Livia Cohen, MS, CTR
Cancer Registry Coordinator
Anne Seneca, MS, RHIA
Health Information Management
Pablo Lavagnini, MD
Curt Heese, MD
Radiation Oncology
Deborah Baldassarre, OCN
Shannon Bristow, RN, MA, HRM
Oncology Nurse
Sharone Jensen, MD
Pain/Palliative Care
Eiko Klimant, MD
Sramila Aithal, MD
Medical Oncology
Evelyn King, MSW
Renee Edwards, MSW
Social Work/Psychosocial
Services Coordinator
Scott Price, MD
Steven Wagner, MD
Diagnostic Radiology
Steve Rusinko, CFO
Kristin Mullen, SVP
Cancer Program Administrator
JJ Hale, BS, CCRC, CCRP
Michelle Niesley, ND, MS, FABNO
Clinical Research Coordinator
Julia Scherer
Faith Williams
Growth/Community
Outreach Coordinator
Nhu Huynh, RD, LDN, CNSC, CSO
Nutrition
Outhayvanh Chan, PharmD
Pharmacy
Benita Stevens, OTR/L, CLT
Gina Smith, PT, CLT
Oncology Rehabilitation
Melanie Corbman, MS, LCGC
Marty Weinar, RN, MS, CCRC
Genetics
EASTERN REGIONAL MEDICAL CENTER |
2
Cancer Committee
Chairman’s Report
CTCA at Eastern is a leading cancer center for comprehensive,
compassionate, patient-centered and integrative cancer care.
Fernando U. Garcia, MD
Cancer Committee
Chairman
The Cancer Committee at CTCA at Eastern,
established in 2006, is a multidisciplinary
committee comprising physicians from the
diagnostic and treatment specialties and nonphysicians from administrative and supportive
services. The Cancer Committee is responsible
for ensuring the American College of Surgeon’s
Commission on Cancer’s (CoC) standards are met
and exceeded. The committee meets regularly
throughout the year. Committee members are
appointed to coordinate important aspects of the
cancer program. The Cancer Committee has the
authority to make recommendations to improve
the overall quality of patient-centered cancer care.
In 2014, Eastern was re-surveyed by the American
College of Surgeon’s CoC. The survey evaluated
Eastern for compliance with national standards for
cancer care. The CoC found Eastern in compliance
with all standards at the time of the survey
along with all eight standard commendations
and awarded Eastern the Three-Year with
Commendation Gold Award, its highest award
level. The CoC recognizes this achievement with
the Outstanding Achievement Award, given to
facilities that are eligible for commendations and
which exceed standards in all areas of the cancer
program set by the CoC. The Cancer Committee
continues to review and monitor these standards
and has begun complying with new standards to
be reviewed at our next CoC survey in 2017.
In 2012, Eastern was awarded certification from the
National Accreditation Program for Breast Centers
(NAPBC). The Cancer Committee has oversight over
the Breast Committee and monitors the standards
which were approved by the NAPBC in May, 2015.
The Cancer Committee reviewed Eastern’s initiative
to become a Breast Center of Excellence and set
the goal to develop a Breast Center of Excellence
Breast Cancer Pathway last year.
Eastern was invited by the Pennsylvania Health
Care Quality Alliance (PHCQA) to share its Cancer
Program Practice Profile Reporting (CP3R) results
on its website. In 2014, Eastern made these
outcomes available to the public. This allowed
patients to review Eastern’s outcomes and
compare them to other facilities in Pennsylvania.
This level of transparency helps ensure that the
public can make the most informed decisions in
choosing a facility for their cancer care.
The Cancer Committee continues to monitor
and review cancer data shared with the Cancer
Program Practice Profile Reporting (CP3R) and the
Rapid Quality Reporting System (RQRS). The Cancer
Committee reviews the data for appropriate cancer
treatment based on National Comprehensive
Cancer Network (NCCN) guidelines and makes
recommendations to exceed the standard of care.
Although only a partial list, the Cancer Committee
is responsible to review and evaluate:
• Cancer Registry activity
• Clinical and programmatic goals
• Community outreach
• Clinic cancer research and genetics
The Cancer Committee at Eastern ensures
that the care of our patients is approached in
a multidisciplinary fashion prescribed by NCCN
guidelines and encompasses physician and
non-physician professions.
Sincerely,
Fernando U. Garcia, MD
EASTERN REGIONAL MEDICAL CENTER |
3
2014 Cancer Conference Report
CTCA at Eastern holds two weekly cancer conferences. One is a General
Cancer Conference with discussions of patients with various cancer sites
and one conference is a site-specific Breast Cancer Conference. Both
conferences are attended by a multidisciplinary team that discusses
individual patient treatment.
The discussion encompasses the patient’s medical
history and physical exam, family history of
cancer, radiology films presented by a radiologist,
pathology presented by a pathologist and
discussions of treatment planning using evidencebased treatment guidelines by surgeons and
oncologists. The patient’s cancer stage, prognostic
indicators, and options for clinical trial participation
are also discussed. A Cancer Conference provides
multidisciplinary treatment planning to help ensure
that our patients benefit from the collaboration of
our team of dedicated experts, and contributes to
physician and allied medical staff education. The
most frequently discussed cancer cases reflect our
top five cancer sites which are lung, breast, colon,
pancreas and prostate. Discussions are not limited
to these sites, however, and often include unusual
and challenging cases. The number of patients
discussed exceeds 15 percent of the total number
of cancer patients treated at Eastern annually. The
members use the information shared at the Cancer
Conference to help make treatment decisions
which benefit the patients who are discussed, and
all of the patients in our care.
EASTERN REGIONAL MEDICAL CENTER |
4
Cancer Registry Report
Established in 2006, the Cancer Registry is an information system designed for
the collection, management, and analysis of data on our patients. The information
collected includes, but is not limited to, demographic information, diagnostic
findings, cancer site, type and extent, cancer therapy and follow-up.
Once collected, the information
is continually reviewed for quality
assurance by the Cancer Registry
staff and physicians for correctness
and completeness of data. The
Cancer Registry database retains
cancer patient information from 2006
through 2013 on 3,216 patients who
were treated for initial diagnosis and
treatment, as well as information on
4,241 patients treated for their cancer
progression or metastasis. In 2013, the
Cancer Registry collected data on 565
patients who were treated for their
initial diagnosis and treatment and
558 patients who were treated for
their cancer progression or metastasis.
The Cancer Registry database is
used to provide information to many
departments including research to
help determine appropriateness of
specific clinical trials at Eastern as
well as administration that may use
the data to review Eastern’s patient
population to identify areas for
continuous patient care improvement.
Examples of the type of data available
are shown in the charts.
Besides providing accurate data, the
Cancer Registry is an integral part of
the Cancer Committee. The Cancer
Registry reviews the American College
of Surgeon’s Commission on Cancer
standards and communicates any
standards changes to the Cancer
Committee. Working with various
departments, the Cancer Registry
coordinates the standards to ensure
Eastern’s continuing accreditation as
a Commission on Cancer-approved
Cancer Program.
NUMBER OF PATIENTS TREATED AT EASTERN BY AGE GROUP (2006–2013)
3500
3058
3000
2500
1896
2000
1758
1500
1000
500
0
647
584
30-39
40-49
50-59
60-69
Other
The majority of patients
treated at Eastern
between 2006 and 2013
were between 40 and
69 with a mean age of
54. The national mean
age at cancer diagnosis
is 67 (American Cancer
Society). Eastern treats
patients at diagnosis
who are younger than
the national average.
TOP FIVE CANCERS TREATED AT EASTERN
1800
1500
Male
Eastern treats more
women with lung
cancer than men—
even though national
statistics show more
men than women are
diagnosed with lung
cancer (American
Cancer Society).
1591
Female
1200
900
564 607
600
300
256 248
501
336 300
15
0
Colon Pancreas Bronchus and Lung
0
Breast Prostate
NUMBER OF PATIENTS TREATED AT EASTERN SINCE 2006
1500
1228 1250
1200
1062
900
600
680
783
1125
817
This graph reflects the
number of patients
treated annually at
Eastern since 2006.
504
300
0
2006 2007 2008 2009 2010 2011 2012 2013
EASTERN REGIONAL MEDICAL CENTER |
5
2013* Primary Sites
SUMMARY BY BODY SYSTEM, SEX, CLASS,
STATUS AND BEST CS/AJCC STAGE REPORT
PRIMARY SITE
Sex
Class of Case
Stage Distribution—Analytic Cases Only
TOTAL (%)
M
F
ANALY
NA
STG 0
STG I
STG II
STG III STG IV
88
ORAL CAVITY AND PHARYNX
31 (2.8%)
18
13
15
16
0
1
2
3
9
0
Tongue
12 (1.1%)
7
5
7
5
0
1
1
2
3
0
Salivary Glands
3 (0.3%)
3
0
2
1
0
0
1
1
0
0
Floor of Mouth
3 (0.3%)
2
1
2
1
0
0
0
0
2
0
Gum and Other Mouth
5 (0.4%)
2
3
2
3
0
0
0
0
2
0
Tonsil
7 (0.6%)
3
4
2
5
0
0
0
0
2
0
Oropharynx
1 (0.1%)
1
0
0
1
0
0
0
0
0
0
305 (27.1%)
182
123
146
159
1
8
15
30
91
1
DIGESTIVE SYSTEM
Esophagus
9 (0.8%)
6
3
7
2
0
1
1
2
3
0
Stomach
40 (3.6%)
26
14
24
16
0
3
0
3
18
0
Small Intestine
6 (0.5%)
4
2
3
3
0
0
0
0
3
0
Colon Excluding Rectum
78 (6.9%)
46
32
32
46
0
3
4
6
19
0
15
7
8
6
9
0
0
0
1
5
0
Appendix
6
3
3
2
4
0
0
0
2
0
0
Ascending Colon
15
6
9
7
8
0
2
1
1
3
0
Hepatic Flexure
4
4
0
1
3
0
0
1
0
0
0
Transverse Colon
4
3
1
3
1
0
0
0
0
3
0
Splenic Flexure
1
1
0
0
1
0
0
0
0
0
0
Cecum
Descending Colon
6
5
1
2
4
0
0
1
0
1
0
Sigmoid Colon
22
12
10
10
12
0
1
1
2
6
0
Large Intestine, NOS
Rectum and Rectosigmoid
Rectosigmoid Junction
5
5
0
1
4
0
0
0
0
1
0
44 (3.9%)
31
13
14
30
1
0
1
6
6
0
16
12
4
4
12
0
0
1
1
2
0
28
19
9
10
18
1
0
0
5
4
0
Anus, Anal Canal and Anorectum
7 (0.6%)
0
7
2
5
0
0
1
1
0
0
Liver and Intrahepatic Bile Duct
Rectum
27 (2.4%)
21
6
16
11
0
0
0
7
8
1
Liver
21
19
2
11
10
0
0
0
6
4
1
Intrahepatic Bile Duct
6
2
4
5
1
0
0
0
1
4
0
Gallbladder
5 (0.4%)
1
4
0
5
0
0
0
0
0
0
Other Biliary
12 (1.1%)
5
7
3
9
0
1
0
1
1
0
Pancreas
74 (6.6%)
42
32
45
29
0
0
8
4
33
0
Retroperitoneum
1 (0.1%)
0
1
0
1
0
0
0
0
0
0
Peritoneum, Omentum and Mesentery
2 (0.2%)
0
2
0
2
0
0
0
0
0
0
193 (17.2%)
96
95
110
81
0
7
3
21
78
1
2 (0.2%)
0
2
1
1
0
0
0
0
1
0
RESPIRATORY SYSTEM
Nose, Nasal Cavity and Middle Ear
7 (0.6%)
5
2
3
4
0
0
0
0
2
1
183 (16.3%)
90
93
106
77
0
7
3
21
75
0
1 (0.1%)
1
0
0
1
0
0
0
0
0
0
BONES AND JOINTS
5 (0.4%)
5
0
1
4
0
1
0
0
0
0
SOFT TISSUE (Including Heart)
13 (1.2%)
5
8
4
9
0
1
0
3
0
0
SKIN (Excluding Basal and Squamous)
11 (1.0%)
6
5
4
7
2
0
0
2
0
0
Larynx
Lung and Bronchus
Trachea, Mediastinum and Other
Respiratory Organs
*2013 is the most complete data due to capturing complete treatment on each case.
EASTERN REGIONAL MEDICAL CENTER |
6
SUMMARY BY BODY SYSTEM, SEX, CLASS,
STATUS AND BEST CS/AJCC STAGE REPORT
PRIMARY SITE
Sex
TOTAL (%)
M
F
Class of Case
Stage Distribution—Analytic Cases Only
ANALY
STG 0
NA
STG I
STG II
STG III STG IV
88
11 (1.0%)
6
5
4
7
2
0
0
2
0
0
BREAST
239 (21.2%)
1
238
136
103
18
38
34
27
19
0
Melanoma—Skin
FEMALE GENITAL SYSTEM
106 (9.4%)
0
106
30
76
0
9
2
7
12
0
Cervix Uteri
16 (1.4%)
0
16
2
14
0
1
0
1
0
0
Corpus and Uterus, NOS
34 (3.0%)
0
34
9
25
0
5
0
1
3
0
Corpus Uteri
29
0
29
8
21
0
4
0
1
3
0
Uterus, NOS
5
0
5
1
4
0
1
0
0
0
0
Ovary
50 (4.4%)
0
50
17
33
0
2
2
4
9
0
Vagina
2 (0.2%)
0
2
0
2
0
0
0
0
0
0
Vulva
1 (0.1%)
0
1
1
0
0
0
0
1
0
0
Other Female Genital Organs
3 (0.3%)
0
3
1
2
0
1
0
0
0
0
MALE GENITAL SYSTEM
77 (6.8%)
77
0
41
36
0
5
19
10
7
0
Prostate
75 (6.7%)
75
0
39
36
0
4
19
9
7
0
Testis
2 (0.2%)
2
0
2
0
0
1
0
1
0
0
URINARY SYSTEM
40 (3.6%)
25
15
19
21
3
4
2
1
9
0
Urinary Bladder
13 (1.2%)
8
5
8
5
3
1
1
0
3
0
Kidney and Renal Pelvis
27 (2.4%)
17
10
11
16
0
3
1
1
6
0
BRAIN/OTHER NERVOUS SYSTEM
19 (1.7%)
13
6
6
13
0
0
0
0
0
6
Brain
16 (1.4%)
12
4
5
11
0
0
0
0
0
5
Cranial Nerves, Other Nervous System
3 (0.3%)
1
2
1
2
0
0
0
0
0
1
ENDOCRINE SYSTEM
23 (2.0%)
9
14
19
4
0
7
0
3
7
2
Thyroid
16 (1.4%)
5
11
15
1
0
7
0
3
5
0
Other Endocrine (including Thymus)
7 (0.6%)
4
3
4
3
0
0
0
0
2
2
LYMPHOMA
33 (2.9%)
18
15
20
13
0
1
4
8
7
0
Hodgkin Lymphoma
9 (0.8%)
4
5
5
4
0
1
0
1
3
0
Hodgkin–Nodal
8
4
4
4
4
0
1
0
0
3
0
Hodgkin–Extranodal
1
0
1
1
0
0
0
0
1
0
0
24 (2.1%)
14
10
15
9
0
0
4
7
4
0
NHL–Nodal
17
11
6
10
7
0
0
2
6
2
0
NHL–Extranodal
7
3
4
5
2
0
0
2
1
2
0
MYELOMA
8 (0.7%)
4
4
4
4
0
0
0
0
0
4
LEUKEMIA
5 (0.4%)
2
3
3
2
0
0
0
0
0
3
Lymphocytic Leukemia
Non-Hodgkin Lymphoma
4 (0.4%)
2
2
2
2
0
0
0
0
0
2
Chronic Lymphocytic Leukemia
2
1
1
1
1
0
0
0
0
0
1
Other Lymphocytic Leukemia
2
1
1
1
1
0
0
0
0
0
1
Other Leukemia
1 (0.1%)
0
1
1
0
0
0
0
0
0
1
MESOTHELIOMA
2 (0.2%)
2
0
0
2
0
0
0
0
0
0
KAPOSI SARCOMA
1 (0.1%)
1
0
0
1
0
0
0
0
0
0
MISCELLANEOUS
14 (1.2%)
10
4
7
7
0
0
0
0
0
7
1125
474
651
565
560
24
82
81
115
239
24
TOTAL
EXCLUSIONS: Not Male and Not Female
EASTERN REGIONAL MEDICAL CENTER |
7
2014 Estimated Leading New Cancer Cases*
MEN (%)
SITE
WOMEN (%)
UNITED STATES
EASTERN
Colon and Rectum 9
5
Breast
2924
Kidney and Renal Pelvis 5
1
Colon and Rectum 9
3
Leukemia
31
Kidney and Renal Pelvis
3
1
Lung and Bronchus
14
10
Lung and Bronchus
14
9
Melanoma of the Skin
5
1
Melanoma of the Skin
4
1
Non-Hodgkin Lymphoma
4
1
Non-Hodgkin Lymphoma
4
1
Oral Cavity and Pharynx
3
2
Ovary
33
Pancreas
35
Pancreas
33
Prostate
287
Thyroid
62
Urinary Bladder
6
1
Uterine Corpus
6
2
All Other Sites
20
66
All Other Sites
19
51
TOTAL SITE
100%100%
UNITED STATES
TOTAL EASTERN
100%100%
* New Leading Cancer Cases 2014 estimates from the American Cancer Society Cancer Facts and Figures 2014, compared with 2013 analytic data at Eastern.
2013
1,125
TOTAL NEW CASES BY STATE FOR
EASTERN REGIONAL MEDICAL CENTER
7
2
197
2
2
1
2
1
194
211
29
5
9
16
1
2
20
86
51
3
1
17
2
22
91
1
8
3
67
12
19
1
31
* Three international patients
are not shown on map.
VIRGIN ISLANDS
6
EASTERN REGIONAL MEDICAL CENTER |
8
Cancer Liaison Physician Report
Submitted by Russell M. Reisner, MD, FACS
Cancer Liaison, Cancer Committee
The Cancer Liaison Physician (CLP) is a volunteer physician from the
medical staff responsible for providing the leadership and direction
to monitor, maintain, and improve quality. The CLP’s primary
responsibilities are to monitor, interpret, and report performance using
the National Cancer Data Base (NCDB) data to evaluate and improve the
quality of cancer care at CTCA at Eastern. The CLP is a required member
of the Cancer Committee and reports the results of this analysis to the
Cancer Committee at least four times a year.
The review of the 2012 Cancer Program Practice
Profile Report (CP3R) shows that Eastern meets
and exceeds the Commission on Cancer’s (CoC)
standards of care for the following:
•Radiation therapy is administered within one
year (365 days) of diagnosis for women under
age 70 receiving breast-conserving surgery
for breast cancer.
•Combination chemotherapy is considered or
administered within four months of diagnosis for
woman under 70 with an AJCC (stage T1cN0M)
or stage II or stage III estrogen receptive and
progesterone receptive negative breast cancer.
•Tamoxifen or third-generation aromatase
inhibitor is considered or administered with
one year of diagnosis for women with an
AJCC (stage T1cN0M0), or stage II or stage III
estrogen receptive and/or progesterone
positive breast cancer.
•Adjuvant chemotherapy is considered or
administered within four months of diagnosis
for patients under the age of 80 with an AJCC
stage III colon cancer.
•At least 12 regional lymph nodes are removed
and pathologically examined for resected
colon cancer.
•Radiation therapy is considered or administered
within six months of diagnosis for patients
under the age of 80 with clinical or pathologic
AJCC stage T4N0M0 or stage III receiving surgical
resection for rectal cancer.
2014 NEW CP3R MEASURES
•Radiation therapy is considered or administered
within one year (365 days) of diagnosis for
women undergoing mastectomy for breast
cancer with ≥4 positive regional lymph nodes.
•Needle biopsy is performed prior to surgical
treatment of breast cancer.
•Breast conservation rate for women with AJDCC
stage 0, stage I, or stage II breast cancer.
•Systemic chemotherapy is considered or
administered within four months pre-operatively
or six months post-operatively for surgically
resected cases with pathologic lymph node
positive (pN1/pN2) non-small cell lung cancer.
EASTERN REGIONAL MEDICAL CENTER |
10
•Surgery is not the initial treatment for patients
with AJC clinical N2 non-small cell lung cancer.
•Ten or more lymph nodes are pathologically
examined for resected non-small cell
lung cancer.
•Chemotherapy is considered or administered
within four months pre-operatively or three
months post-operatively for AJCC stage IB-Iv-M0
gastric cancers.
•Fifteen or more lymph nodes are pathologically
examined for resected gastric cancers.
•Neo-adjuvant chemotherapy and radiation is
considered or administered within four months
pre-operatively for AJCC clinical stage T3-T4
N0M0 or T1-T4 N1 M0 esophageal cancers.
•Esophageal surgical volumes are measured.
• Pancreatic surgical volumes are measured.
REVISION FOR RECTAL CANCER
•Chemotherapy/radiation is considered or
administered within three months preoperatively, or chemotherapy is considered or
administered within 90 days post-operatively
for AJCC stage II or stage III rectal cancer.
Background: The performance rates shown in
the Cancer Program Practice Profile Reports
(CP3R) match the specifications of the breast,
colon and rectal cancer care measures endorsed
by the National Quality Forum in April 2007.
The CoC has instituted the CP3R as a facility
feedback mechanism to promote awareness
of the importance of abstracting accuracy and
completeness in line with evidence-based
practice guidelines.
By interpreting and reviewing the NCDB data,
the CLP helps ensure that Eastern’s patients are
receiving quality cancer care that is monitored,
maintained, and improved to the CTCA level
of standard of care.
EASTERN REGIONAL MEDICAL CENTER |
11
Comprehensive Services
Our Technologies, Treatments and Services
Cardiology
Echocardiogram (ECHO)
Electrocardiogram (EKG)
Holter Monitors
Nuclear Medicine Rest/Stress Test
Transesophageal Echocardiogram (TEE)
Chemotherapy/Immunotherapy/
Targeted Therapy
Hormone Therapy
Induction and Consolidation
Chemotherapy
Intra-Arterial Chemotherapy (IAC)
Intraperitoneal Chemotherapy (IPC)
Intrathecal Chemotherapy
Intravenous Chemotherapy
Metronomic Chemotherapy/
Fractional Dose
Monoclonal Antibody Therapy
Provenge®
Radioimmunotherapy
Targeted Drug Therapy
Targeted Therapy Oral IV
Yervoy™ (for metastatic melanoma)
Zevalin® (for non-Hodgkin lymphoma)
Chiropractic Services
Blood Flow Enhancement
Fatigue Management
Flexibility Enhancement
Joint Mobilization
Mechanical Traction
Nervous System Enhancement
Neuromuscular Reeducation
Soft Tissue Mobilization
Somato-Viscero Reflex Enhancement
Therapeutic Exercise
Critical Care
Intensive Care Unit
Invasive and Minimally Invasive
Cardiac Monitoring
Diagnostics
Imaging
• All Digital: Portable Fluoroscopy
and X-Rays
-- Barium Swallow or Enema
-- Chest X-Ray
• Bone Density
• Computed Tomography (CT) Scan
-- CT Angiography with 3D CT
-- CT Fluoroscopy
• Magnetic Resonance Imaging (MRI)
-- MR Computer-Aided Detection
(CAD)
• Mammography (Full Field Digital)
-- Breast Ductography
-- Breast Needle Localization
-- Mammography
-- MRI-Guided Breast Biopsy
-- MR Computer-Aided Detection
(CAD) for Mammography
-- Sentinel Lymph Node Mapping
and Imaging
• Nuclear Medicine Imaging
-- Multiple-Gated Acquisition
(MUGA) Scan
-- Bone Scan
-- SPECT/CT for Nuclear Studies
• Ultrasound
Gastroenterology
Argon Plasma Coagulation (APC)
Celiac Plexus Neurolysis (CPN)
Cholangiopancreatography
Cholangioscopy (SpyGlass™)
Colonoscopy
Endoscopic Mucosal Resection (EMR)
Endoscopic Retrograde
Cholangiopancreatography (ERCP)
Endoscopic Ultrasound (EUS)
Enteroscopy
Esophageal Variceal Banding
Esophagogastroduodenoscopy (EGD)
Flexible Sigmoidoscopy
Nutritional/Metabolic Support
Percutaneous Endoscopic Gastrostomy
(PEG) Placement
Single Balloon Enteroscopy
Stent Placements
Video Capsule Endoscopy
Gynecologic Oncology
Ablation of Intra-Abdominal Tumors
Anterior and Posterior Colporrhaphy
Cervical and Uterine HDR
Brachytherapy
Colposcopy
Cone Biopsy/Loop Electrosurgical
Excision Procedure (LEEP)
Full Range of Open Laparoscopic
Gynecologic Surgery
Full Range of Robotic Gynecologic
Surgery
Ovarian Cancer Debulking and Staging
Radical Vulvectomy
Hematology
Allogeneic
Apheresis Stem Cell Collection
Autologous
Cord Blood
Cryopreservation of Stem Cells for
Transplant
Haploidentical
Matched Sibling Donor
Matched Unrelated Donor
Nonmyeloablative/Reduced-Intensity
Stem Cell Transplant
Plasmapheresis
Interventional Pulmonology
All Digital: Portable Fluoroscopy
and X-Rays
Argon Plasma Coagulation (APC)
Autofluorescence Bronchoscopy
Balloon Bronchoplasty
Bronchoscopy
Cryotherapy
Endobronchial Ultrasound (EBUS)
Fluorescence Bronchoscopy
Navigational Bronchoscopy
Neuroscopy
Pleurodesis (with Chemotherapy
or TalC)/Pleuroscopy
PleurX Tunneled Pleural Catheter
Insertion
Pulmonary Function Testing (PFT)
(including Spirometry, Lung
Capacity Studies, Diffusion Analysis
and Methacholine Airway Challenge)
Rigid Ventilating Bronchoscopy and
Flexible Bronchoscopy
Super-Dimension GPS Bronchoscopy
Transbronchial Needle Aspiration
Interventional Radiology
Ablation
• Cryoablation
• Microwave Ablation
• Irreversible Electroporation
(NanoKnife®)
• Radiofrequency Ablation (RFA)
Abscess Drainage and Fluid Collection
Management
Angiography/Angioplasty/Stent
Placement
Arterial Infusion Catheter Placement
Chest Tube Placement
Inferior Vena Cava Filter
Intrathecal Chemotherapy
Administration
IVC Filter Placement
Percutaneous/Transhepatic Biliary
Drainage (Internal and/or External
Stent Placements)
EASTERN REGIONAL MEDICAL CENTER |
12
Percutaneous Gastrostomy/
Gastrojejunostomy (GI Tube
Placement)
Percutaneous Nephrostomy/Urology
Procedures
Percutaneous Image-Guided Biopsy
Portal Vein Embolization
Thoracentesis
Thrombectomy
Transarterial Therapy
• Intra-Arterial Chemotherapy (IAC)
• Bland Tumor Embolization
• Hepatic Chemoembolization
• Radioembolization (Therasphere®)
Venous Access (PICC, CVC, Port)
Venography
Venous Angioplasty/Stenting – Venous
Stenosis, SVC Syndrome
Vertebral Augmentation (Kyphoplasty)
and Vertebral Tumor Ablation
Vertebroplasty
Vertebral Tumor Coablation
Laboratory Services
Chemistry
Special Chemistry
• Anemia Testing
• Blood Gases
• Endocrine Testing
• Intraoperative PTH
• Lactic Acid
• Procalcitonin
• Tumor Marker Testing
Coagulation
• D-dimer
• Fibrinogen
• Protime
• PTT
Transfusion Services
• ABO/Rh typing
• Antibody Screen and Identification
• Antigen Typing
• Crossmatch
• Red Blood Cell and Platelet Irradiation
• Transfusion Reaction Workup
Hematology
• Automated and Manual Differentials
• Complete Blood Count
• Fluid Cell Counts and Differentials
• Reticulocyte Counts
• Sedimentation Rates
Urinalysis
• C. diff Testing
• Dipstick and Microscopic Analysis
• Occult Blood Testing
• Qualitative HCG
Anatomic Pathology
• Diagnostic Immunohistochemistry
and Special Stains
• Fine Needle Aspirations with
Immediate Assessment
• Intraoperative Consultations and
Frozen Section Evaluations
• Non-Gynecological Cytology of Fluids
• Prognostic Markers for Solid Tumors
• Whole Mount and Grid
Morphometric Analysis of Prostate
Mind-Body Medicine
Behavioral Health Assessment
Counseling (Individual, Couple, Family
for Patients and Caregivers)
Energy Therapies (Qigong, Reiki)
Expressive Arts (Music, Movement)
Laughter/Humor Therapy
Psycho-Educational Groups
Relaxation and Guided Imagery
Training
Stress Management
Support Groups
Systemic Desensitization for
Conditioned Aversions
Naturopathic Medicine
Acupuncture
Acupressure
Assessment and Consultation
Assessment of Herb/Drug and Drug/
Nutrient Interactions
Natural Support during Chemotherapy,
Radiation and Surgery
Nutritional/Dietary Supplements
Vitamins and Minerals
Neurosurgery
Craniotomy
Endonasal Endoscopy
Intensity Modulated Radiation Therapy
(IMRT)
Intraoperative Nerve Monitoring
Intraoperative Ultrasound
Local Chemotherapy (Gliadel® wafers/
BCNU)
Magnetic Resonance Imaging (MRI)
Neuroendoscopy
Nuclear Medicine Bone Scans
Ommaya Reservoir
Positron Emission Tomography
(PET) Scan
Shunt Placement
Spinal Tumors and Spinal
Decompression
Stereotactic Radiosurgery (SRS)
Ventriculoperitoneal Shunt
Nutrition Therapy
Body Composition Analysis
Diabetes Self-Management Education
Program
Indirect Calorimetry Test
Individual Nutrition Assessments and
Counseling
Metabolic Support Including Parenteral
and Enteral Nutrition
Oncology Rehabilitation
Auriculotherapy
Fatigue Management
Lymphedema Management
Occupational Therapy
Physical Therapy
Post Mastectomy Rehab
Pulmonary Rehab
ReBuilder®
Speech and Language Pathology
Orthopedic Oncology
Hip and Joint Placement
Implants (e.g., Metal Implants,
Prosthesis, Transplants)
Limb Salvage Surgery
Rodding/Rod Fixation
Pain Management
Individualized Pain Assessment and
Medical Management
Inpatient and Home Patient
Controlled Analgesia Pump
Interventional Pain Procedures
including:
• Epidural and Intrathecal Catheters
• Celiac Plexus and Other Nerve
Blocks
• Epidural Steroid Injection
• Joint Injection
Pathology
Genomic Tumor Analysis
Tumor Tissue Repository
EASTERN REGIONAL MEDICAL CENTER |
13
Comprehensive Services
Our Technologies, Treatments and Services (cont.)
Radiation Oncology
3D Conformal Radiation
Accelerated Partial Breast
Irradiation (APBI)
Calypso® 4D Localization System™
External Beam Radiation
Therapy (EBRT)
High-Dose Rate (HDR) Brachytherapy
Image Guided Radiation
Therapy (IGRT)
Intensity Modulated Radiation
Therapy (IMRT)
Intraoperative Radiation
Therapy (IORT)
Simulation with Large Bore 16-Slice
CT Scanner
Linear Accelerator
Local Hyperthermia
Deep Tissue Hyperthermia
RapidArc®
Respiratory Gating, RapidArc and SBRT
BrainLAB Stereotactic Radiosurgery
(SRS)/Stereotactic Radiation
Therapy (SRT)
Stereotactic Radiosurgery in
conjunction with Calypso® 4D
Localization
TheraSphere® and SIR-spheres
TomoHDA
Total Body Irradiation (TBI)
Total Marrow Irradiation (TMI)
Varian Linear Accelerator with
Stereotactic Radiosurgery
Spiritual Support
Assistance with Advanced Directives
and/or Living Wills
Forgiveness Program
Grief and Bereavement Counseling
and Referral
Interface with Local Pastor and Church
Nondenominational Worship Services
Our Journey of Hope® Program
Prayer (Individual and Group)
Spiritual Counseling
Surgery
Breast surgery
• Mastectomy, including
Nipplesparing Mastectomy
• Breast Conservation Surgery
(Lumpectomy, Partial Mastectomy)
with Oncoplastic Reconstruction
• Breast Reconstruction
• Fat Stem Cell Transfer for Breast
Contouring
• Intraoperative Radiation Therapy
• Sentinel Node Biopsy
Gastrointestinal Surgery, including
Laparoscopic and Endoscopic
Procedures
• Esophagectomy
• Gastrectomy
• Small Bowel Resection
• Colon Resection
• Rectal Resection, including
Sphincter-sparing Surgery
• Bypass for Malignant Obstruction
• Placement of Feeding Tubes –
Gastrostomy or Jejunostomy
• Endoscopic Placement of
Esophageal, Duodenal, and
Colonic Stents
Hepatobiliary and Pancreatic Surgery
• Liver Resection, including
Laparoscopic
• Liver Tumor Radiofrequency
Ablation
• Gall Bladder and Bile Duct Resection
• Pancreas Resection, including
Whipple Procedure
• Biliary and Intestinal Bypass
• Endoscopic Placement of Biliary and
Pancreatic Stents
Lung and Thoracic Surgery
• Wedge Resection or
Metastastectomy
• Pulmonary Lobectomy or
Pneumonectomy
• Mediastinoscopy
• Thoracoscopic Resections
• Intrabronchial Stenting and Tumor
Ablation
• Endobronchial Ultrasound with
Biopsy
• Pleuroscopy
• Robotic Theoracic Surgery
Peritoneal Surface Malignancies –
Ovarian, Appendiceal, Colon and
Gastric Cancers
• Cytoreductive Surgery (Debulking)
• HIPEC – Hyperthermic Intraperitoneal
Chemotherapy
• Palliative Resection and Bypass
Urology
• Nephrectomy, including Partial
Nephrectomy, Laparoscopic
Nephrectomy
• Prostatectomy
• Cystectomy
• Neobladder Formation
Major Head and Neck Surgeries
• Laryngectomy with Voice Restoration
Procedures
• Composite Resection
• Neck Dissection
• Thryroidectomy
• Orbital Tumor Surgery
Diagnostic and Staging Surgery,
including Minimally Invasive
Techniques
Intraoperative Radiation Therapy for
Pelvic, Intraabodminal,
Retroperitoneal, Head and Neck and
Soft Tissue Malignancies
EASTERN REGIONAL MEDICAL CENTER |
14
Conclusion
As part of a national network of hospitals, CTCA at Eastern offers
an integrative and individualized approach to cancer treatment by
combining surgery, radiation, and chemotherapy, with nutritional
counseling, naturopathic medicine, mind-body therapy and spiritual
support to enhance quality of life and reduce side effects. Known
for delivering the Mother Standard® of care, Eastern is proud to
offer weekend clinic appointments to better meet the needs
of our patients and their families.
The facility currently comprises 427,000 square feet, including the Medical Office
Building, 66 inpatient beds and 11 outpatient accommodations. As of December
2014, Eastern employed 1,011 support staff and 189 physicians. We are proud of
the accomplishments we made in 2014 and excited about 2015, which marks 10
years in Philadelphia.
EASTERN REGIONAL MEDICAL CENTER |
16
800-333-CTCA | cancercenter.com
© 2015 Rising Tide